Cargando…
Transient Elastography for the Detection of Liver Damage in Patients with HIV
INTRODUCTION: Highly active antiretroviral therapy (HAART) is effective and well tolerated, but hepatotoxicity is relatively common. Different non-invasive methods are available for detecting liver fibrosis in patients with chronic liver disease. METHODS: Patients who were HIV positive and who had g...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Healthcare
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4575292/ https://www.ncbi.nlm.nih.gov/pubmed/26143457 http://dx.doi.org/10.1007/s40121-015-0073-y |
_version_ | 1782390755826860032 |
---|---|
author | Sagir, Abdurrahman Glaubach, Birgit Sahin, Kurtulus Graf, Dirk Erhardt, Andreas Oette, Mark Häussinger, Dieter |
author_facet | Sagir, Abdurrahman Glaubach, Birgit Sahin, Kurtulus Graf, Dirk Erhardt, Andreas Oette, Mark Häussinger, Dieter |
author_sort | Sagir, Abdurrahman |
collection | PubMed |
description | INTRODUCTION: Highly active antiretroviral therapy (HAART) is effective and well tolerated, but hepatotoxicity is relatively common. Different non-invasive methods are available for detecting liver fibrosis in patients with chronic liver disease. METHODS: Patients who were HIV positive and who had given their informed consent were included in this cross-sectional study. Transient elastography [FibroScan(®) (FS); Echosens], serum hyaluronic acid (HA), Hepascore (HS), Fibrosis-4 (FIB-4), and aspartate aminotransferase to platelet ratio index (APRI) were used to detect liver fibrosis in the patients. The agreement between FS and the other methods was evaluated. To observe the hepatotoxicity of HAART, patients with chronic viral hepatitis B or C were excluded by detection of hepatitis B surface antigens and hepatitis C virus antibodies. Patients with chronic alcohol intake were excluded by measuring carbohydrate-deficient transferrin (CDT). FS correlation with the duration of therapy with protease inhibitors (PI), nucleoside reverse transcriptase inhibitors (NRTI), and non-nucleoside reverse transcriptase inhibitors (NNRTI) was evaluated. RESULTS: Overall, 203 patients were included in the study. The agreement between the different tests ranged from 64% to 77%: FS vs. HA, 72%; FS vs. APRI, 74%; FS vs. HS, 77%; and FS vs. FIB-4, 64%. After excluding patients with chronic hepatitis B or C and elevated CDT, 153 patients remained for studying the hepatotoxicity of HAART. A significant correlation of FS with the duration of medication intake was observed for PIs (P = 0.026; r = 0.18). NRTI and NNRTI therapy duration did not correlate with FS. CONCLUSIONS: The agreement between FS and other tests ranged from 64% to 77%. A significant correlation was found between liver stiffness and the duration of therapy with PIs, which underlines the known hepatotoxicity of this substance group. FUNDING: Heinz-Ansmann Foundation. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1007/s40121-015-0073-y) contains supplementary material, which is available to authorized users. |
format | Online Article Text |
id | pubmed-4575292 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2015 |
publisher | Springer Healthcare |
record_format | MEDLINE/PubMed |
spelling | pubmed-45752922015-09-23 Transient Elastography for the Detection of Liver Damage in Patients with HIV Sagir, Abdurrahman Glaubach, Birgit Sahin, Kurtulus Graf, Dirk Erhardt, Andreas Oette, Mark Häussinger, Dieter Infect Dis Ther Original Research INTRODUCTION: Highly active antiretroviral therapy (HAART) is effective and well tolerated, but hepatotoxicity is relatively common. Different non-invasive methods are available for detecting liver fibrosis in patients with chronic liver disease. METHODS: Patients who were HIV positive and who had given their informed consent were included in this cross-sectional study. Transient elastography [FibroScan(®) (FS); Echosens], serum hyaluronic acid (HA), Hepascore (HS), Fibrosis-4 (FIB-4), and aspartate aminotransferase to platelet ratio index (APRI) were used to detect liver fibrosis in the patients. The agreement between FS and the other methods was evaluated. To observe the hepatotoxicity of HAART, patients with chronic viral hepatitis B or C were excluded by detection of hepatitis B surface antigens and hepatitis C virus antibodies. Patients with chronic alcohol intake were excluded by measuring carbohydrate-deficient transferrin (CDT). FS correlation with the duration of therapy with protease inhibitors (PI), nucleoside reverse transcriptase inhibitors (NRTI), and non-nucleoside reverse transcriptase inhibitors (NNRTI) was evaluated. RESULTS: Overall, 203 patients were included in the study. The agreement between the different tests ranged from 64% to 77%: FS vs. HA, 72%; FS vs. APRI, 74%; FS vs. HS, 77%; and FS vs. FIB-4, 64%. After excluding patients with chronic hepatitis B or C and elevated CDT, 153 patients remained for studying the hepatotoxicity of HAART. A significant correlation of FS with the duration of medication intake was observed for PIs (P = 0.026; r = 0.18). NRTI and NNRTI therapy duration did not correlate with FS. CONCLUSIONS: The agreement between FS and other tests ranged from 64% to 77%. A significant correlation was found between liver stiffness and the duration of therapy with PIs, which underlines the known hepatotoxicity of this substance group. FUNDING: Heinz-Ansmann Foundation. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1007/s40121-015-0073-y) contains supplementary material, which is available to authorized users. Springer Healthcare 2015-07-05 2015-09 /pmc/articles/PMC4575292/ /pubmed/26143457 http://dx.doi.org/10.1007/s40121-015-0073-y Text en © The Author(s) 2015 https://creativecommons.org/licenses/by-nc/4.0/This article is distributed under the terms of the Creative Commons Attribution Noncommercial License which permits any noncommercial use, distribution, and reproduction in any medium, provided the original author(s) and the source are credited. |
spellingShingle | Original Research Sagir, Abdurrahman Glaubach, Birgit Sahin, Kurtulus Graf, Dirk Erhardt, Andreas Oette, Mark Häussinger, Dieter Transient Elastography for the Detection of Liver Damage in Patients with HIV |
title | Transient Elastography for the Detection of Liver Damage in Patients with HIV |
title_full | Transient Elastography for the Detection of Liver Damage in Patients with HIV |
title_fullStr | Transient Elastography for the Detection of Liver Damage in Patients with HIV |
title_full_unstemmed | Transient Elastography for the Detection of Liver Damage in Patients with HIV |
title_short | Transient Elastography for the Detection of Liver Damage in Patients with HIV |
title_sort | transient elastography for the detection of liver damage in patients with hiv |
topic | Original Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4575292/ https://www.ncbi.nlm.nih.gov/pubmed/26143457 http://dx.doi.org/10.1007/s40121-015-0073-y |
work_keys_str_mv | AT sagirabdurrahman transientelastographyforthedetectionofliverdamageinpatientswithhiv AT glaubachbirgit transientelastographyforthedetectionofliverdamageinpatientswithhiv AT sahinkurtulus transientelastographyforthedetectionofliverdamageinpatientswithhiv AT grafdirk transientelastographyforthedetectionofliverdamageinpatientswithhiv AT erhardtandreas transientelastographyforthedetectionofliverdamageinpatientswithhiv AT oettemark transientelastographyforthedetectionofliverdamageinpatientswithhiv AT haussingerdieter transientelastographyforthedetectionofliverdamageinpatientswithhiv |